Epidrug Screening Identifies Type I PRMT Inhibitors as Modulators of Lysosomal Exocytosis and Drug Sensitivity in Cancers
Ontology highlight
ABSTRACT: Epidrug Screening Identifies Type I PRMT Inhibitors as Modulators of Lysosomal Exocytosis and Drug Sensitivity in Cancers
PROVIDER: PRJNA1162511 | ENA |
REPOSITORIES: ENA
ACCESS DATA